Literature DB >> 20103566

A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blotting.

Fredrick O Onono1, Michael A Morgan, H Peter Spielmann, Douglas A Andres, Thangaiah Subramanian, Arnold Ganser, Christoph W M Reuter.   

Abstract

Prenylation is a post-translational modification critical for the proper function of multiple physiologically important proteins, including small G-proteins, such as Ras. Methods allowing rapid and selective detection of protein farnesylation and geranylgeranylation are fundamental for the understanding of prenylated protein function and for monitoring efficacy of drugs such as farnesyltransferase inhibitors (FTIs). Although the natural substrates for prenyltransferases are farnesyl pyrophosphate and geranylgeranyl pyrophosphate, farnesyltransferase has been shown to incorporate isoprenoid analogues into protein substrates. In this study, protein prenyltransferase targets were labeled using anilinogeraniol, the alcohol precursor to the unnatural farnesyl pyrophosphate analogue 8-anilinogeranyl diphosphate in a tagging-via-substrate approach. Antibodies specific for the anilinogeranyl moiety were used to detect the anilinogeranyl-modified proteins. Coupling this highly effective labeling/detection method with two-dimensional electrophoresis and subsequent Western blotting allowed simple, rapid analysis of the complex farnesylated proteome. For example, this method elucidated the differential effects induced by two chemically distinct FTIs, BMS-214,662 and L-778,123. Although both FTIs strongly inhibited farnesylation of many proteins such as Lamins, NAP1L1, N-Ras, and H-Ras, only the dual prenylation inhibitor L-778,123 blocked prenylation of Pex19, RhoB, K-Ras, Cdc42, and Rap1. This snapshot approach has significant advantages over traditional techniques, including radiolabeling, anti-farnesyl antibodies, or mass spectroscopy, and enables dynamic analysis of the farnesylated proteome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103566      PMCID: PMC2860237          DOI: 10.1074/mcp.M900597-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  41 in total

Review 1.  Farnesylated proteins and cell cycle progression.

Authors:  F Tamanoi; J Kato-Stankiewicz; C Jiang; I Machado; N Thapar
Journal:  J Cell Biochem Suppl       Date:  2001

2.  Analysis of the eukaryotic prenylome by isoprenoid affinity tagging.

Authors:  Uyen T T Nguyen; Zhong Guo; Christine Delon; Yaowen Wu; Celine Deraeve; Benjamin Fränzel; Robin S Bon; Wulf Blankenfeldt; Roger S Goody; Herbert Waldmann; Dirk Wolters; Kirill Alexandrov
Journal:  Nat Chem Biol       Date:  2009-02-15       Impact factor: 15.040

3.  Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

Authors:  R B Lobell; C A Omer; M T Abrams; H G Bhimnathwala; M J Brucker; C A Buser; J P Davide; S J deSolms; C J Dinsmore; M S Ellis-Hutchings; A M Kral; D Liu; W C Lumma; S V Machotka; E Rands; T M Williams; S L Graham; G D Hartman; A I Oliff; D C Heimbrook; N E Kohl
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway.

Authors:  Konstantinos Stamatakis; Eva Cernuda-Morollón; Octavio Hernández-Perera; Dolores Pérez-Sala
Journal:  J Biol Chem       Date:  2002-10-15       Impact factor: 5.157

5.  Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB.

Authors:  Sarah A Holstein; Christine L Wohlford-Lenane; Raymond J Hohl
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

6.  Isoprenoids influence expression of Ras and Ras-related proteins.

Authors:  Sarah A Holstein; Christine L Wohlford-Lenane; Raymond J Hohl
Journal:  Biochemistry       Date:  2002-11-19       Impact factor: 3.162

7.  Design and synthesis of a transferable farnesyl pyrophosphate analogue to Ras by protein farnesyltransferase.

Authors:  K A Chehade; D A Andres; H Morimoto; H P Spielmann
Journal:  J Org Chem       Date:  2000-05-19       Impact factor: 4.354

8.  Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor.

Authors:  W C Rose; F Y Lee; C R Fairchild; M Lynch; T Monticello; R A Kramer; V Manne
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

9.  In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

Authors:  Bruno B Bordier; Junko Ohkanda; Ping Liu; So-Young Lee; F H Salazar; Patricia L Marion; Kazuo Ohashi; Leonard Meuse; Mark A Kay; John L Casey; Said M Sebti; Andrew D Hamilton; Jeffrey S Glenn
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Antigenic prenylated peptide conjugates and polyclonal antibodies to detect protein prenylation.

Authors:  Xiao-hui Liu; Dae-Yeon Suh; Jeffrey Call; Glenn D Prestwich
Journal:  Bioconjug Chem       Date:  2004 Mar-Apr       Impact factor: 4.774

View more
  26 in total

1.  Evaluation of alkyne-modified isoprenoids as chemical reporters of protein prenylation.

Authors:  Amanda J DeGraw; Charuta Palsuledesai; Joshua D Ochocki; Jonathan K Dozier; Stepan Lenevich; Mohammad Rashidian; Mark D Distefano
Journal:  Chem Biol Drug Des       Date:  2010-10-11       Impact factor: 2.817

Review 2.  Recent advances in protein prenyltransferases: substrate identification, regulation, and disease interventions.

Authors:  Elaina A Zverina; Corissa L Lamphear; Elia N Wright; Carol A Fierke
Journal:  Curr Opin Chem Biol       Date:  2012-11-08       Impact factor: 8.822

3.  Expansion of protein farnesyltransferase specificity using "tunable" active site interactions: development of bioengineered prenylation pathways.

Authors:  James L Hougland; Soumyashree A Gangopadhyay; Carol A Fierke
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

4.  Measurement of protein farnesylation and geranylgeranylation in vitro, in cultured cells and in biopsies, and the effects of prenyl transferase inhibitors.

Authors:  Norbert Berndt; Saïd M Sebti
Journal:  Nat Protoc       Date:  2011-10-27       Impact factor: 13.491

5.  Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.

Authors:  Hong Jiang; Xiaoyu Zhang; Xiao Chen; Pornpun Aramsangtienchai; Zhen Tong; Hening Lin
Journal:  Chem Rev       Date:  2018-01-02       Impact factor: 60.622

6.  Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.

Authors:  Michael A Morgan; Fredrick O Onono; H Peter Spielmann; Thangaiah Subramanian; Michaela Scherr; Letizia Venturini; Iris Dallmann; Arnold Ganser; Christoph W M Reuter
Journal:  J Mol Med (Berl)       Date:  2011-09-14       Impact factor: 4.599

7.  Human CaaX protease ZMPSTE24 expressed in yeast: Structure and inhibition by HIV protease inhibitors.

Authors:  Kathleen M Clark; Jermaine L Jenkins; Nadia Fedoriw; Mark E Dumont
Journal:  Protein Sci       Date:  2016-11-11       Impact factor: 6.725

8.  Efficient use of exogenous isoprenols for protein isoprenylation by MDA-MB-231 cells is regulated independently of the mevalonate pathway.

Authors:  Fredrick Onono; Thangaiah Subramanian; Manjula Sunkara; Karunai Leela Subramanian; H Peter Spielmann; Andrew J Morris
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

9.  A combination of metabolic labeling and 2D-DIGE analysis in response to a farnesyltransferase inhibitor facilitates the discovery of new prenylated proteins.

Authors:  Charuta C Palsuledesai; Joshua D Ochocki; Todd W Markowski; Mark D Distefano
Journal:  Mol Biosyst       Date:  2014-05

10.  Identification of a farnesol analog as a Ras function inhibitor using both an in vivo Ras activation sensor and a phenotypic screening approach.

Authors:  Kamalakkannan Srinivasan; Thangaiah Subramanian; H Peter Spielmann; Chris Janetopoulos
Journal:  Mol Cell Biochem       Date:  2013-11-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.